CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.5B
AUM Growth
+$378M
(+2.7%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
738
New
61
Increased
261
Reduced
285
Closed
31
Top Buys
| 1 |
Visa
V
|
$77.8M |
| 2 |
Gilead Sciences
GILD
|
$59.3M |
| 3 |
Microsoft
MSFT
|
$46.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$40.2M |
| 5 |
Nu Holdings
NU
|
$39.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$112M |
| 2 |
Royal Bank of Canada
RY
|
$51.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$42.8M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.9M |
| 5 |
Merck
MRK
|
$33.3M |
Sector Composition
| 1 | Technology | 30.32% |
| 2 | Healthcare | 28.88% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.52% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Pliant Therapeutics
PLRX
$114M
| $8.2M | 0.06% |
453,000
+138,000
| +44% | +$2.5M |
|
277
Paycom
PAYC
$12.6B
| $8.16M | 0.06% |
39,463
-7,421
| -16% | -$1.53M |
|
278
PTC Therapeutics
PTCT
$4.55B
| $8.04M | 0.06% |
291,652
| – | – |
|
279
Blackrock
BLK
$170B
| $7.96M | 0.05% |
9,800
-358
| -4% | -$291K |
|
280
Relay Therapeutics
RLAY
$710M
| $7.94M | 0.05% |
721,070
-250,000
| -26% | -$2.75M |
|
281
Amicus Therapeutics
FOLD
$2.46B
| $7.86M | 0.05% |
553,879
-25,000
| -4% | -$355K |
|
282
iShares MSCI India ETF
INDA
$9.26B
| $7.83M | 0.05% |
160,370
+10,900
| +7% | +$532K |
|
283
Kura Oncology
KURA
$713M
| $7.79M | 0.05% |
541,417
-150,005
| -22% | -$2.16M |
|
284
RAPT Therapeutics
RAPT
$214M
| $7.78M | 0.05% |
39,158
| – | – |
|
285
Annaly Capital Management
NLY
$14.2B
| $7.76M | 0.05% |
400,774
+357,260
| +821% | +$6.92M |
|
286
Penumbra
PEN
$11B
| $7.69M | 0.05% |
30,573
-14,319
| -32% | -$3.6M |
|
287
Denali Therapeutics
DNLI
$2.26B
| $7.68M | 0.05% |
357,878
| – | – |
|
288
Badger Meter
BMI
$5.39B
| $7.42M | 0.05% |
48,087
+6,833
| +17% | +$1.05M |
|
289
Option Care Health
OPCH
$4.72B
| $7.41M | 0.05% |
+220,000
| New | +$7.41M |
|
290
Tractor Supply
TSCO
$32.1B
| $7.33M | 0.05% |
170,415
-27,910
| -14% | -$1.2M |
|
291
Urban Outfitters
URBN
$6.35B
| $7.28M | 0.05% |
204,001
-180,631
| -47% | -$6.45M |
|
292
Deere & Co
DE
$128B
| $7.24M | 0.05% |
18,096
-258
| -1% | -$103K |
|
|
MORF
293
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.22M | 0.05% |
249,933
| – | – |
|
294
AT&T
T
$212B
| $7.16M | 0.05% |
426,734
-23,456
| -5% | -$394K |
|
295
American Tower
AMT
$92.9B
| $7.12M | 0.05% |
32,987
+2,135
| +7% | +$461K |
|
296
Ultragenyx Pharmaceutical
RARE
$3.07B
| $7.1M | 0.05% |
148,480
+99,000
| +200% | +$4.73M |
|
|
CERE
297
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $7.09M | 0.05% |
167,221
-160,000
| -49% | -$6.78M |
|
298
Krystal Biotech
KRYS
$4.35B
| $6.82M | 0.05% |
55,000
-15,000
| -21% | -$1.86M |
|
299
Arch Capital
ACGL
$34.1B
| $6.78M | 0.05% |
91,244
+26,815
| +42% | +$1.99M |
|
300
Axsome Therapeutics
AXSM
$6.25B
| $6.77M | 0.05% |
85,084
+35,000
| +70% | +$2.79M |
|